首页|血府逐瘀汤联合西药治疗慢性阻塞性肺疾病的Meta分析

血府逐瘀汤联合西药治疗慢性阻塞性肺疾病的Meta分析

扫码查看
目的 系统评价血府逐瘀汤联合西医常规治疗慢性阻塞性肺疾病的疗效。方法 使用计算机查阅以下数据库:中国知网(CNKI)、维普(VIP)、中国生物医学文献数据库(CBM)、万方、PubMed、Cochrane Library、Embase等数据库。查阅内容为血府逐瘀汤联合西医常规治疗慢性阻塞性肺疾病的临床随机对照试验,查阅时间为以上数据库建库起至2023年7月。由两名评估人员通过Cochrane风险偏倚从随机方法、分配隐藏、盲法、结局数据、选择报道、其他偏倚方面以High risk、Low risk及Unclear risk评价文献质量。运用RevMan 5。3软件对提取的数据进行Meta分析。结果 共纳入27项随机对照研究,共计囊括1 861例患者,其中观察组934例,对照组927例。Meta分析结果:中医疗效:血府逐瘀汤联合西医常规治疗效果优于单用西医常规治疗[OR=4。11,95%CI(2。85,5。91),Z=7。61,P<0。000 01]。肺功能:第1秒用力呼气容积(FEV1)明显改善[MD=0。19,95%CI(0。05,0。32),Z=2。68,P=0。007];用力肺活量(FVC)明显改善[MD=0。17,95%CI(0。09,0。25),Z=4。19,P<0。000 1];第1秒用力呼气容积占用力肺活量的百分比(FEV1/FVC)明显改善[MD=3。23,95%CI(1。66,4。80),Z =4。03,P<0。000 1];血气分析:动脉血氧分压(PaO2)显著改善[MD=5。79,95%CI(3。44,8。13),Z=4。84,P<0。000 01];动脉血二氧化碳分压(PaCO2)显著改善[MD=-3。85,95%CI(-6。09,-1。61),Z=3。38,P=0。000 7]。血流变:血浆黏度改善[MD=-0。33,95%CI(-0。52,-0。14),Z=3。37,P=0。000 8];红细胞压积差异无统计学意义[MD=-0。04,95%CI(-0。13,0。04),Z=1。00,P=0。32];纤维蛋白原明显改善[MD=-0。77,95%CI(-0。95,-0。59),Z=8。24,P<0。000 01]。6分钟步行试验改善[MD=33。04,95%CI(16。81,49。26),Z=3。99,P<0。000 1]。结论在传统西药基础上结合血府逐瘀汤方治疗慢性阻塞性肺疾病对多个结局指标有明显改善。
Meta-analysis of Xuefu Zhuyu Decoction combined with western medicine for chronic obstructive pulmonary disease
Objective To evaluate the curative effect of Xuefu Zhuyu Decoction combined with conventional western medicine on chronic obstructive pulmonary disease.Methods The following databases were searched by computer:CNKI,VIP,CBM,Wanfang,PubMed,Cochrane Library,Embase,etc.The content of the review was the clinical randomized controlled trial of Xuefu Zhuyu Decoction combined with conventional western medicine in the treatment of chronic obstructive pulmonary disease,and the review time was from the establishment of the above database to July 2023.Cochrane risk bias was used by two reviewers to evaluate literature quality with High risk,Low risk and Unclear risk in terms of randomization,assignment concealment,blindness,outcome data,selection reports and other biases.Meta-analysis of the extracted data was performed using RevMan 5.3 software.Results A total of 27 randomized controlled studies were included,involving a total of 1 861 patients,of whom 934 were in the observation group and 927 were in the control group.Results of meta-analysis:curative effect of traditional Chinese medicine:Xuefu Zhuyu Decoction combined with conventional western medicine treatment was better than conventional western medicine treatment alone[OR=4.11,95%CI(2.85,5.91),Z= 7.61,P<0.000 01].Pulmonary function:FEV1 was significantly improved[MD=0.19,95%CI(0.05,0.32),Z=2.68,P=0.007].FVC obviously improved[MD = 0.17,95%CI(0.09,0.25),Z = 4.19,P<0.000 1];FEV1/FVC obviously improved[MD = 3.23,95%CI(1.66,4.80),Z = 4.03,P<0.000 1];Blood gas analysis:PaO2 was significantly improved[MD= 5.79,95%CI(3.44,8.13),Z= 4.84,P<0.000 01],PaCO2 significantly improved[MD =-3.85,95%CI(-6.09,-1.61),Z = 3.38,P =0.000 7].The plasma viscosity improved[MD =-0.33,95%CI(-0.52,-0.14),Z = 3.37,P = 0.000 8].No statistical differences of red blood cells deposited[MD =-0.04,95%CI(-0.13,0.04),Z = 1.00,P = 0.32].Fibrinogen significantly improved[MD =-0.77,95%CI(-0.95,-0.59),Z = 8.24,P<0.000 01].The 6-minute walking test improved[MD = 33.04,95%CI(16.81,49.26),Z= 3.99,P<0.000 1].Conclusion On the basis of traditional western medicine combined with Xuefu Zhuyu Decoction in the treatment of chronic obstructive pulmonary disease,many outcome indexes can be significantly improved.

Xuefu Zhuyu DecoctionChronic obstructive pulmonary diseaseMeta-analysisEvidence-based medicine

孙佳、齐亚丽、陈燚含、李洋、王琪、王艳学

展开 >

青海大学,西宁 810000

青海省人民医院,西宁 810000

贵德县河西镇中心卫生院,青海海南 813000

血府逐瘀汤 慢性阻塞性肺疾病 Meta分析 循证医学

2024

中国处方药
南方医药经济研究所

中国处方药

影响因子:0.649
ISSN:1671-945X
年,卷(期):2024.22(4)
  • 32